{
    "code": "56028318",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56028318",
    "time": "2020-02-26 07:54:20",
    "許可證字號": "衛部醫器輸字第028318號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "110\/03\/29",
    "發證日期": "105\/03\/29",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602831800",
    "中文品名": "邦迪斯歐普羅免疫球蛋白次群G1分析套組",
    "英文品名": "The Binding Site Optilite IgG1 Kit",
    "效能": "本產品搭配邦迪斯歐普羅系統使用，用來體外定量存在於血清、使用肝素鋰鹽和使用EDTA當作抗凝劑的血漿中的免疫球蛋白次群G1。",
    "醫器規格": "NK006.OPT。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器主類別二": [
        ""
    ],
    "醫器主類別三": "",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "6231118886  太暘生物科技股份有限公司",
        "申請商地址": "新北市汐止區福德三路369號12樓",
        "主製造廠": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560283180001-105-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56028318&Seq=001&Type=9"
        },
        {
            "title": "560283180002-105-04-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56028318&Seq=001&Type=8"
        }
    ]
}